(Q45862517)

English

Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver

scientific article published in May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

1 reference

based on heuristic

inferred from title

author name string

Kuriyama S

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Tominaga K

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Kikukawa M

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Tsujimoto T

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Nakatani T

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Tsujinoue H

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Okuda H

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Nagao S

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Mitoro A

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Yoshiji H

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Fukui H

11

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

publication date

1 May 1999

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

749-757

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

https://scigraph.springernature.com/pub.10.1038/sj.gt.3300894

0 references

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Manipulation of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

21 January 2018

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

7 January 2021

based on heuristic

inferred from DOI database lookup

A Potential Approach for Gene Therapy Targeting Hepatoma Using a Liver-Specific Promoter on a Retroviral Vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300894

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3300894

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/10505097

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45862517&oldid=2086804989"